Rockefeller Capital Management L.P. Acadia Pharmaceuticals Inc Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 1,139,934 shares of ACAD stock, worth $19.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,139,934

Previous 954,250 19.46%

Holding current value

$19.6 Million

Previous $15.5 Million 13.14%

% of portfolio

0.05%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $2.81 Million - $3.55 Million	185,684 Added 19.46%	1,139,934 $17.5 Million
Q2 2024 Aug 12, 2024	BUY	$14.62 - $18.42 $2.42 Million - $3.05 Million	165,798 Added 21.03%	954,250 $15.5 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $4.13 Million - $7.16 Million	232,115 Added 41.72%	788,452 $14.6 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $1.06 Million - $1.63 Million	51,164 Added 10.13%	556,337 $17.4 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $2.1 Million - $3.38 Million	100,884 Added 24.95%	505,173 $10.5 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $1.36 Million - $1.96 Million	-76,591 Reduced 15.93%	404,289 $9.68 Million
Q1 2023 May 17, 2023	BUY	$16.32 - $20.92 $281,340 - $360,639	17,239 Added 3.72%	480,880 $9.05 Million
Q4 2022 Mar 06, 2023	BUY	$14.2 - $18.63 $68,316 - $89,628	4,811 Added 1.05%	463,641 $7.38 Million
Q3 2022 Nov 02, 2022	BUY	$14.11 - $18.27 $332,925 - $431,080	23,595 Added 5.42%	458,830 $7.51 Million
Q2 2022 Aug 12, 2022	BUY	$13.01 - $27.22 $1.53 Million - $3.2 Million	117,500 Added 36.98%	435,235 $6.13 Million
Q1 2022 May 13, 2022	BUY	$20.94 - $27.5 $319,104 - $419,072	15,239 Added 5.04%	317,735 $7.69 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $357,089 - $576,150	21,268 Added 7.56%	302,496 $7.06 Million
Q3 2021 Nov 12, 2021	BUY	$15.78 - $24.77 $783,382 - $1.23 Million	49,644 Added 21.44%	281,228 $4.67 Million
Q2 2021 Aug 10, 2021	BUY	$19.4 - $27.42 $4.39 Million - $6.2 Million	226,222 Added 4218.99%	231,584 $5.65 Million
Q1 2021 May 11, 2021	BUY	$25.02 - $54.99 $62,399 - $137,145	2,494 Added 86.96%	5,362 $138,000
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $126,977 - $175,708	-3,094 Reduced 51.9%	2,868 $152,000
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $216,516 - $338,865	5,945 Added 34970.59%	5,962 $245,000
Q2 2020 Aug 12, 2020	BUY	$39.26 - $52.73 $667 - $896	17 New	17 $1,000
Q2 2019 Aug 09, 2019	SELL	$23.32 - $28.12 $1,585 - $1,912	-68 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$16.17 - $27.38 $1,099 - $1,861	68 New	68 $2,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.78B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Acadia Pharmaceuticals Inc Transaction History